Should Americans be worried about prescription medications coming in from Canada and other countries?

The U.S. Food and Drug Administration posted a warning letter to CanaRx for facilitating the distribution of unapproved new drugs and misbranded drugs to U.S. consumers. Lars speaks with Tom DiLenge who is the President of Advocacy, Law and Public Policy for Biotechnology Innovation to speak on this topic. Listen below.